Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James S. Hanson currently holds 19,092 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James S. Hanson has been a net buyer of GTHX stock. They have purchased $116.3K and sold $45.6K worth of shares.
James S. Hanson's most recent insider trade was on Sep 9, 2025, when they sold 1,677 shares at $10.23 per share.
James S. Hanson serves as Executive at G1 Therapeutics, Inc. (GTHX). They have executed 17 insider transactions totaling $161.9K over their tenure at the company.
James S. Hanson holds the position of Executive at G1 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
James S. Hanson has shown a buying trading pattern, with $116.3K in total purchases and $45.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James S. Hanson was on Jun 3, 2024, when they sold $55.4K worth of FTRE shares. This transaction involved 2,231 shares at $24.85 per share.
James S. Hanson currently owns 19,092 shares of G1 Therapeutics, Inc. (GTHX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James S. Hanson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James S. Hanson has 17 Form 4 filings on record as an insider at G1 Therapeutics, Inc..
Set alerts for James S. Hanson and 40,000+ other insiders.